Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials
- Citation:
- Clin Cancer Res vol 25 (14) 4422-30
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Presented at American Society of Clinical Oncology Annual Meeting 2017
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2857
- Children:
- None
- Pharmas:
- Genentech
- Grants:
- U10CA180821, UG1CA189867 (NRG NCORP), U10CA180822 (NRG Oncology SDMC [Biostats]), U24CA196067 (NRG BSB) (Lab), U24CA196171 (Alliance biorepository)
- Corr. Author:
- Authors:
- Saranya Chumsri Daniel J. Serie Zhuo Li Katherine L. Pogue-Geile Aixa E. Soyano-Muller Afshin Mashadi-Hossein Sarah Warren Yanyan Lou Gerardo Colon-Otero Keith L. Knutson Edith A. Perez Alvaro Moreno-Aspitia E. Aubrey Thompson
- Networks:
- LAPS-MN026, NY021, PR028
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N9831, NSABP B-31
- Phases:
- 3
- Keywords: